生物技术公司Moderna, Inc. (MRNA) 今日盘中股价大幅下跌5.06%，引起了市场的关注。
消息面上，Moderna宣布，已承诺在2026年7月8日或之前，向合作方Arbutus Biopharma及其子公司Genevant Sciences支付一笔总额高达9.5亿美元的无条件一次性款项。市场分析认为，这笔大额支出可能对公司的现金流和短期财务表现构成压力，从而引发了投资者的担忧和抛售。
值得注意的是，尽管有分析师（贝伦贝格）在近期将其目标价从32美元上调至45美元，显示出对其长期前景的看好，但今日股价的剧烈波动主要反映了市场对上述大额支付事件的即时反应。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.